CORD-19:c738a511a9c18e7e831b40f1ec3605fe4cdeb6d1 / 6488-6771 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T39","span":{"begin":0,"end":283},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Patients with early-stage, node-negative, ER+ breast cancer can safely begin radiotherapy 8-12 weeks after breast conserving surgery without compromising disease control or survival, with several large studies showing that a delay up to 20 weeks may be safe in an appropriate subset."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T39","span":{"begin":0,"end":283},"obj":"Sentence"}],"text":"Patients with early-stage, node-negative, ER+ breast cancer can safely begin radiotherapy 8-12 weeks after breast conserving surgery without compromising disease control or survival, with several large studies showing that a delay up to 20 weeks may be safe in an appropriate subset."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T17","span":{"begin":46,"end":59},"obj":"Phenotype"}],"attributes":[{"id":"A17","pred":"hp_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/HP_0003002"}],"text":"Patients with early-stage, node-negative, ER+ breast cancer can safely begin radiotherapy 8-12 weeks after breast conserving surgery without compromising disease control or survival, with several large studies showing that a delay up to 20 weeks may be safe in an appropriate subset."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T21","span":{"begin":46,"end":52},"obj":"Body_part"},{"id":"T22","span":{"begin":107,"end":113},"obj":"Body_part"}],"attributes":[{"id":"A21","pred":"uberon_id","subj":"T21","obj":"http://purl.obolibrary.org/obo/UBERON_0000310"},{"id":"A22","pred":"uberon_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/UBERON_0000310"}],"text":"Patients with early-stage, node-negative, ER+ breast cancer can safely begin radiotherapy 8-12 weeks after breast conserving surgery without compromising disease control or survival, with several large studies showing that a delay up to 20 weeks may be safe in an appropriate subset."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T46","span":{"begin":42,"end":59},"obj":"Disease"},{"id":"T47","span":{"begin":46,"end":59},"obj":"Disease"},{"id":"T48","span":{"begin":53,"end":59},"obj":"Disease"},{"id":"T56141","span":{"begin":42,"end":59},"obj":"Disease"},{"id":"T46908","span":{"begin":46,"end":59},"obj":"Disease"},{"id":"T60127","span":{"begin":53,"end":59},"obj":"Disease"}],"attributes":[{"id":"A46","pred":"mondo_id","subj":"T46","obj":"http://purl.obolibrary.org/obo/MONDO_0006512"},{"id":"A47","pred":"mondo_id","subj":"T47","obj":"http://purl.obolibrary.org/obo/MONDO_0007254"},{"id":"A48","pred":"mondo_id","subj":"T48","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"},{"id":"A40953","pred":"mondo_id","subj":"T56141","obj":"http://purl.obolibrary.org/obo/MONDO_0006512"},{"id":"A59037","pred":"mondo_id","subj":"T46908","obj":"http://purl.obolibrary.org/obo/MONDO_0007254"},{"id":"A21482","pred":"mondo_id","subj":"T60127","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"}],"text":"Patients with early-stage, node-negative, ER+ breast cancer can safely begin radiotherapy 8-12 weeks after breast conserving surgery without compromising disease control or survival, with several large studies showing that a delay up to 20 weeks may be safe in an appropriate subset."}